GHRP-6 10 mg — GH Secretagogue & Appetite Stimulant

GHRP-6

GH secretagogue and appetite stimulant

99% Purity Growth Hormone

GHRP-6 (Growth Hormone Releasing Peptide-6) is a hexamer peptide that stimulates the pulsatile release of growth hormone (GH) from the pituitary gland by activating the ghrelin receptor. Unlike other GHRPs, GHRP-6 produces a pronounced secondary effect: a significant increase in appetite, which makes it a useful option for athletes in a muscle-gain (bulking) phase or for individuals who struggle to raise their caloric intake.

Key Benefits

Raises endogenous GH naturally

Markedly increases appetite

Facilitates muscle gain during bulking

Improves sleep quality

Accelerates post-workout recovery

Supports joint regeneration

Mechanism of Action

GHRP-6 activates the ghrelin receptor (GHS-R1a) in the pituitary gland, triggering a natural pulsatile release of growth hormone (GH). This same pathway stimulates hypothalamic hunger signaling, which explains its pronounced orexigenic effect.

Verify Product Contact

Protocol

Reconstitution & Usage Protocol

Important: Only chill the water for 3 minutes before reconstituting the peptide. Do not prepare it with very cold water, because it can freeze, lose potency, or be damaged.

1Reconstitution

Materials: 1 vial of GHRP-6 10 mg · 1 vial of bacteriostatic water · U-100 insulin syringe · 3 mL syringe · alcohol wipes.

Let the vial reach room temperature for 10–15 minutes.
Disinfect the rubber caps with an alcohol wipe.
Draw 3 mL of bacteriostatic water with the 3 mL syringe.
Inject the water slowly down the vial wall.
Do not shake. Swirl gently until the solution is clear.

Label with the date and refrigerate (2–8 °C). Stable for 28 days.

2Concentration & Dosing

Reconstituting 10 mg in 3 mL → 3.33 mg/mL ≈ 33.3 mcg per IU.

Target dose	Units	Volume
200 mcg (standard)	6 IU	0.06 mL
300 mcg (high)	9 IU	0.09 mL

Universal formula: IU = (dose in mcg ÷ 33.3)

3Application

Route

Subcutaneous in the abdomen.

Frequency

2–3 times per day (morning, pre-workout, before sleep).

Cycle

8–12 weeks with a 4-week break. Frequently stacked with CJC-1295 No DAC.

Use on an empty stomach: intake of carbohydrates or fats 30 min before/after reduces the GH pulse.
Before applying: let the drawn dose lose its chill (only the amount to be injected) — hold the syringe in your hand for 2–3 minutes.
After applying: gently massage the area for ~40 seconds to disperse the peptide and improve absorption.

Importante: Solo poner a enfriar el agua 3 minutos antes de reconstituir el péptido. No preparar con agua muy fría, porque se puede congelar, perder efecto o dañarse.

1Reconstitución

Materiales: 1 vial de GHRP-6 10 mg · 1 vial de agua bacteriostática · jeringa de insulina U-100 · jeringa de 3 mL · toallitas de alcohol.

Atemperar el vial 10–15 minutos.
Desinfectar las tapas de goma con toallita de alcohol.
Cargar 3 mL de agua bacteriostática con jeringa de 3 mL.
Inyectar el agua lentamente por la pared del vial.
No agitar. Girar suavemente hasta solución transparente.

Etiquetar con fecha y refrigerar (2–8 °C). Estable 28 días.

2Concentración y dosis

Reconstituyendo 10 mg en 3 mL → 3,33 mg/mL ≈ 33,3 mcg por UI.

Dosis objetivo	Unidades	Volumen
200 mcg (estándar)	6 UI	0,06 mL
300 mcg (alta)	9 UI	0,09 mL

Fórmula universal: UI = (dosis en mcg ÷ 33,3)

3Aplicación

Vía

Subcutánea en abdomen.

Frecuencia

2–3 veces al día (mañana, pre-entreno, antes de dormir).

Ciclo

8–12 semanas con descanso de 4 semanas. Frecuentemente stackeado con CJC-1295 No DAC.

Tomar en ayunas: la ingesta de carbohidratos o grasas 30 min antes/después reduce el pulso de GH.
Antes de aplicar: dejar que la dosis cargada pierda el frío (solo la cantidad a inyectar) — sostener la jeringa en la mano 2–3 minutos.
Después de aplicar: masaje suave en la zona durante ~40 segundos para dispersar el péptido y mejorar la absorción.

Important : Ne refroidir l'eau que 3 minutes avant de reconstituer le peptide. Ne pas préparer avec de l'eau très froide, car il peut geler, perdre son effet ou être endommagé.

1Reconstitution

Matériel : 1 flacon de GHRP-6 10 mg · 1 flacon d'eau bactériostatique · seringue à insuline U-100 · seringue de 3 mL · lingettes d'alcool.

Laisser le flacon revenir à température 10–15 minutes.
Désinfecter les bouchons en caoutchouc avec une lingette d'alcool.
Prélever 3 mL d'eau bactériostatique avec la seringue de 3 mL.
Injecter l'eau lentement le long de la paroi du flacon.
Ne pas agiter. Faire tourner doucement jusqu'à obtenir une solution transparente.

Étiqueter avec la date et réfrigérer (2–8 °C). Stable 28 jours.

2Concentration et dosage

En reconstituant 10 mg dans 3 mL → 3,33 mg/mL ≈ 33,3 mcg par UI.

Dose cible	Unités	Volume
200 mcg (standard)	6 UI	0,06 mL
300 mcg (élevée)	9 UI	0,09 mL

Formule universelle : UI = (dose en mcg ÷ 33,3)

3Application

Voie

Sous-cutanée dans l'abdomen.

Fréquence

2–3 fois par jour (matin, avant l'entraînement, avant le coucher).

Cycle

8–12 semaines avec une pause de 4 semaines. Fréquemment associé au CJC-1295 No DAC.

À jeun : la prise de glucides ou de lipides 30 min avant/après réduit le pic de GH.
Avant l'application : laisser la dose prélevée perdre son froid (uniquement la quantité à injecter) — tenir la seringue dans la main 2–3 minutes.
Après l'application : masser doucement la zone pendant ~40 secondes pour disperser le peptide et améliorer l'absorption.

Open dosage calculator →

Research Highlights

Preclinical models indicate GHRP-6 stimulates pituitary GH release by activating the GHS-R1a receptor, the same target engaged by endogenous ghrelin, without suppressing the HPG axis.
Research highlights a pronounced orexigenic signal, with GHRP-6 markedly increasing food-seeking behavior in study models compared with more selective secretagogues.
Comparative studies report that co-administration with a GHRH analog such as CJC-1295 amplifies the GH pulse beyond either compound used alone.

FAQ

Frequently Asked Questions

What is GHRP-6 in research terms?

GHRP-6 is a synthetic hexamer growth-hormone secretagogue studied as a ghrelin-receptor (GHS-R1a) agonist. In study models it triggers a natural pulsatile release of pituitary GH while also activating hypothalamic hunger signaling, giving it a pronounced orexigenic profile. It is supplied strictly as a laboratory reference compound for in-vitro and non-human research use.

Why is GHRP-6 associated with such a strong appetite effect?

Because GHRP-6 acts on the GHS-R1a receptor — the same target as endogenous ghrelin, the body's hunger hormone — study models show it strongly activates hypothalamic appetite signaling alongside the GH pulse. This marked orexigenic response is more pronounced than with more selective secretagogues, which is precisely why it is selected when an appetite-stimulating profile is a variable of interest. All observations describe research models only.

What administration route and timing are used in research models?

In published protocols GHRP-6 is administered subcutaneously in the abdomen, and its short-acting, pulsatile profile means timing matters more than a long half-life. Models commonly schedule it 2–3 times per day — fasted, before sleep, or post-exercise — to align with natural GH rhythms, since carbohydrate or fat intake 30 minutes before or after can blunt the GH pulse. These parameters describe laboratory study design and are not human-use instructions.

Can GHRP-6 be stacked with CJC-1295 in research?

A frequently studied pairing is GHRP-6 with the GHRH analog CJC-1295 No DAC, where the secretagogue and GHRH pathways act synergistically to amplify the GH pulse beyond either compound alone. Each is reconstituted and handled separately under aseptic technique, and study cycles commonly run 8–12 weeks with a 4-week break. All such combinations are for controlled laboratory investigation only and never for human use.

Related Compounds

← Previous

IGF-1 LR3

Ipamorelin

← Back to full catalog